Patent Assignment
Reel/Frame 049600/0497
Assignment of Assignor's Interest
Recorded: 2019-06-26
Pages: 8
Assignee
CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
ROBINSON BUILDING, CHESTERFORD RESEARCH PARK, SAFFRON WALDEN, ESSEX, CB10 1XL, UNITED KINGDOM
Covered Property
(1)
Inhibitors of Plasma Kallikrein and Uses Thereof
Patent:
10,730,874 →
Application:
16/299,996 →
Publication:
US 2019/0284182
PCT:
PCT/US2019/021897 ↗
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 26, 2019
From: BIODURO LLC
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 049600/0564 →
Assignment of Assignor's Interest
Jun 26, 2019
From: PAPAIOANNOU, NIKOLAOS; MILLER, THOMAS ALLEN; SHIPPS, GERALD WAYNE, JR.; TRAVINS, JEREMY MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 049600/0536 →
Assignment of Assignor's Interest
Jun 26, 2019
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 049600/0552 →
Assignment of Assignor's Interest
Jun 26, 2019
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 049600/0583 →
Assignment of Assignor's Interest
Jun 26, 2019
From: CHARLES RIVER LABORATORIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 049600/0587 →
Assignment of Assignor's Interest
Mar 30, 2021
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055766/0572 →
Assignment of Assignor's Interest
Mar 14, 2022
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 059250/0619 →